Congress Must Consider Accurate Data About Patent Thickets
Just before Christmas, Congress added — and then abruptly dropped — a section of a proposed spending bill aimed at limiting the number of patents pharmaceutical manufacturers could assert in patent...To view the full article, register now.
Already a subscriber? Click here to view full article